Search:

Search for text in:

separate each search
term with a space

Multiple terms:

Additional Search Filters:

clear all | select all

Conference Years:

clear all | select all

Days Within Meeting:

clear all | select all

Conferences:

Availability:

clear all | select all

Participation Type:

clear all | select all

Topic Tracks*:

clear all | select all

Organ Site Tracks*:

Showing session: reset

From Chemistry to the Clinic: Pathways for Drug Discovery and Development, Part 1: Optimizing Drug Discovery: Insights on an Important Process

  • Sort by:
  • Browse by:
<< first | < prev page: of 1 records per page: next > | last >>
pages: 1 presentations: 1 to 4 of 4
From Chemistry to the Clinic: Pathways for Drug Discovery and Development, Part 1: Optimizing Drug Discovery: Insights on an Important Process
Introduction
Michael J. Luzzio
Biogen Idec, Inc., Cambridge, MA, United States
from AACR Annual Meeting 2015 on April 18, 2015 8:00 AM-10:00 AM
From Chemistry to the Clinic: Pathways for Drug Discovery and Development, Part 1: Optimizing Drug Discovery: Insights on an Important Process
  •  
  • Permission not
    granted for presentation
  •  
  •  
Discovery of a potent covalent mutant-selective EGFR inhibitor: The journey from high throughput screening to EGF816
Gerald Lelais
Genomics Institute of the Novartis Research Institute, San Diego, CA, United States
from AACR Annual Meeting 2015 on April 18, 2015 8:00 AM-10:00 AM
From Chemistry to the Clinic: Pathways for Drug Discovery and Development, Part 1: Optimizing Drug Discovery: Insights on an Important Process
  •  
  • Permission not
    granted for presentation
  •  
  •  
Lead optimization through modulation of physicochemical properties: A case study in the discovery of novel CDK9 inhibitors
Yunsong Tong
AbbVie Inc., North Chicago, IL, United States
from AACR Annual Meeting 2015 on April 18, 2015 8:00 AM-10:00 AM
From Chemistry to the Clinic: Pathways for Drug Discovery and Development, Part 1: Optimizing Drug Discovery: Insights on an Important Process
Discovery of pan-notch inhibitors as anticancer agents
Ashvinikumar V. Gavai
Bristol-Myers Squibb Co., Princeton, NJ, United States
from AACR Annual Meeting 2015 on April 18, 2015 8:00 AM-10:00 AM
<< first | < prev page: of 1 records per page: next > | last >>
pages: 1 presentations: 1 to 4 of 4